Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ting Niu
Sichuan University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
147
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
1.
Inaticabtagene Autoleucel ((CNCT19), a CD19-Directed Chimeric Antigen Receptor T-Cell Therapy in Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: A Multicenter, Open-Label, Single-Arm, Phase 2 Study
Number of pages: 25
Posted: 09 Feb 2024
Ying Wang
,
LuLu Lv
,
Xudong Wei
,
Yongping Song
,
Hongsheng Zhou
,
Qifa Liu
,
Kailin Xu
,
Dongmei Yan
,
Cheng Zhang
,
Shuangyou Liu
,
Jie Jin
,
Heng Mei
, Ting Niu,
Aibin Liang
,
Yiwei Song
,
Jienan Ren
,
Wei Jin
,
Yan Zhou
,
Yiping Deng
,
Changting C. Haudenschild
and
Jianxiang Wang
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Juventas Cell Therapy Ltd, Zhengzhou University - Henan Cancer Hospital, Zhengzhou University, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Xuzhou Medical University, Xuzhou Medical University, Government of the People's Republic of China - Xinqiao Hospital, Beijing Gobroad Boren Hospital, Zhengzhou University, Huazhong University of Science and Technology - Institute of Hematology, Sichuan University, Tongji University, Juventas Cell Therapy Ltd, Juventas Cell Therapy Ltd, Juventas Cell Therapy Ltd, Juventas Cell Therapy Ltd, Juventas Cell Therapy Ltd, Juventas Cell Therapy Ltd and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology
Downloads
147
View PDF
Download
Abstract:
inati-cel, CNCT19, adult, relapsed or refractory B-cell acute lymphoblastic leukaemia, CD19 CAR-T
Feedback